American Healthcare REIT ("AHR") Announces First Quarter 2024 Results
Key Highlights:
- Reported GAAP net loss attributable to common stockholders of
$(0.04) per basic and diluted share for the three months endedMarch 31, 2024 . - Reported Normalized Funds from Operations attributable to common stockholders ("NFFO") of
$0.30 per basic and diluted share for the three months endedMarch 31, 2024 . - Achieved 7.1% total portfolio Same-Store ("SS") revenue growth for the three months ended
March 31, 2024 compared to the same period in 2023, largely driven by improved performance in the Company's RIDEA-operated assets. - Achieved total portfolio Same-Store Net Operating Income ("NOI") growth of 13.0% for the three months ended
March 31, 2024 compared to the same period in 2023, highlighted by 33.5% and 19.9% Same-Store NOI growth from its senior housing operating properties ("SHOP") and integrated senior health campuses ("ISHC"), respectively. - Disposed of approximately
$15.6 million ofNon-Core Properties across the Company's outpatient medical ("OM") and SHOP segments. - Acquired a 14-property portfolio in
Oregon for approximately$94.5 million that is managed by Compass Senior Living in a RIDEA structure. - Completed a public offering of 64.4 million shares of its common stock priced at a public offering price of
$12.00 per share and listed such common stock on theNew York Stock Exchange ("NYSE") under the symbol "AHR". - Paid down approximately
$721.5 million of outstanding debt obligations carrying a weighted average interest rate of approximately 7.5%, substantially improving leverage metrics and providing the Company with additional borrowing capacity and flexibility.
"After completing our offering and listing event in February, our main focus is on delivering strong operating performance across our property segments. The year is off to a solid start, as we captured outsized growth within our RIDEA-operated assets due to the supply-demand imbalance present in the senior housing industry. Our assets are well positioned and staffed appropriately to capitalize on further near-term demand tailwinds, which we believe will drive additional occupancy gains and rate growth," said
First Quarter 2024 Results
The Company's active asset management continues to strengthen top-line growth, in addition to effectively managing controllable expenses. In aggregate, NOI growth remains on track to achieve the growth contemplated within the Company's 2024 total portfolio Same-Store NOI growth guidance range.
SS NOI Growth Rates: Quarter Ended |
|
Segment |
NOI Growth |
ISHC OM SHOP
Total Portfolio |
19.9% 1.0% 33.5% 4.3% 13.0% |
"Our hands-on active asset management approach is proving its merits, as evidenced by the stellar performance of our recently acquired
Full Year 2024 Guidance
The Company's following guidance ranges for the year ending
|
Full Year 2024 Guidance |
|
Metric |
FY 2024 Range |
FY 2024 Midpoint |
NAREIT FFO per share NFFO per share
Total Portfolio SS NOI Growth
Segment-Level SS NOI Growth / (Decline): ISHC OM SHOP
|
5.0% to 7.0%
8.0% to 10.0% (0.5)% to 0.0% 25.0% to 30.0% 1.0% to 3.0% |
6.0%
9.0% (0.3)% 27.5% 2.0% |
Certain of the assumptions underlying the Company's 2024 guidance can be found within the Non-GAAP reconciliations in this earnings release and in the appendix of the Company's First Quarter 2024 Supplemental Financial Information ("Supplemental"). A reconciliation of Net Loss calculated in accordance with GAAP to NAREIT FFO and NFFO can be found within the Non-GAAP reconciliations in this earnings release. Non-GAAP financial measures and other terms, as used in this earnings release, are also defined and further explained in the Supplemental. The Company does not provide guidance for the most comparable GAAP financial measures of total revenues and property operating and maintenance expenses. Additionally, a reconciliation of the forward-looking non-GAAP financial measures of Same-Store NOI growth to the comparable GAAP financial measures cannot be provided without unreasonable effort because the Company is unable to reasonably predict certain items contained in the GAAP measures, including non-recurring and infrequent items that are not indicative of the Company's ongoing operations. Such items include, but are not limited to, impairment on depreciated real estate assets, net (gain)/loss on sale of previously depreciated real estate assets, stock-based compensation, casualty loss, non-Same-Store revenues, and non-Same-Store operating expenses. These items are uncertain, depend on various factors, and could have a material impact on the Company's GAAP results for the guidance period. |
Transaction Activity
As previously announced, on
Additionally, during the three months ended
Subsequent to quarter end, through the
Capital Markets and Balance Sheet Activity
As previously announced, during the three months ended
As of
"Utilizing proceeds from our public offering in February, we were able to pay down floating-rate indebtedness, bringing our net-debt-to-Adjusted EBITDA ratio down to 6.4x at the end of the first quarter. We believe that the organic earnings growth embedded in our previously announced Normalized FFO and Same-Store portfolio guidance for the remainder of the year should result in further improvement to our leverage ratios," said
Distribution
As previously announced, the Company's Board of Directors declared a cash distribution for the quarter ended
Supplemental Information
The Company has disclosed supplemental information regarding its portfolio, financial position and results of operations as of
Conference Call and Webcast Information
The Company will host a webcast and conference call at
To join via webcast, investors may use the following link: https://events.q4inc.com/attendee/167736636.
Alternatively, to join via telephone, please pre-register at the following link.
A digital replay of the call will be available on our website at https://ir.americanhealthcarereit.com shortly after the conclusion of the call.
Forward-Looking Statements
Certain statements contained in this press release, including statements relating to the Company's expectations regarding its interest expense savings, balance sheet, net income or loss per share, FFO per share, NFFO per share, total portfolio Same-Store NOI growth, segment-level Same-Store NOI growth, occupancy, NOI growth, revenue growth, margin expansion and plans for Trilogy may be considered forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. The Company intends for all such forward-looking statements to be covered by the applicable safe harbor provisions for forward-looking statements contained in those acts. Such forward-looking statements generally can be identified by the use of forward-looking terminology, such as "may," "will," "can," "expect," "intend," "anticipate," "estimate," "believe," "continue," "possible," "initiatives," "focus," "seek," "objective," "goal," "strategy," "plan," "potential," "potentially," "preparing," "projected," "future," "long-term," "once," "should," "could," "would," "might," "uncertainty" or other similar words. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. Any such forward-looking statements are based on current expectations, estimates and projections about the industry and markets in which the Company operates, and beliefs of, and assumptions made by, the Company's management and involve known and unknown risks and uncertainties that could cause actual results to differ materially from those expressed or implied therein, including, without limitation, risks disclosed in the Company's periodic reports filed with the
Non-GAAP Financial Measures
The Company's reported results are presented in accordance with GAAP. The Company also discloses the following non-GAAP financial measures: NAREIT FFO, NFFO, NOI, Same-Store NOI, EBITDA and Adjusted EBITDA. The Company believes these non-GAAP financial measures are useful supplemental measures of its operating performance and used by investors and analysts to compare the operating performance of the Company between periods and to other REITs or companies on a consistent basis without having to account for differences caused by unanticipated and/or incalculable items. Definitions of the non-GAAP financial measures used herein and reconciliations to the most directly comparable financial measure calculated in accordance with GAAP can be found at the end of this earnings release.
About
CONDENSED CONSOLIDATED BALANCE SHEETS
As of (In thousands) (Unaudited) |
|||
|
|||
|
|
|
|
ASSETS |
|||
Real estate investments, net |
$ 3,478,773 |
|
$ 3,425,438 |
Debt security investment, net |
87,984 |
|
86,935 |
Cash and cash equivalents |
77,026 |
|
43,445 |
Restricted cash |
47,505 |
|
47,337 |
Accounts and other receivables, net |
215,881 |
|
185,379 |
Identified intangible assets, net |
187,814 |
|
180,470 |
|
234,942 |
|
234,942 |
Operating lease right-of-use assets, net |
221,575 |
|
227,846 |
Other assets, net |
151,930 |
|
146,141 |
Total assets |
$ 4,703,430 |
|
$ 4,577,933 |
|
|
|
|
LIABILITIES, REDEEMABLE NONCONTROLLING INTERESTS AND EQUITY |
|||
Liabilities: |
|
|
|
Mortgage loans payable, net |
$ 1,228,435 |
|
$ 1,302,396 |
Lines of credit and term loan, net |
759,308 |
|
1,223,967 |
Accounts payable and accrued liabilities |
257,283 |
|
242,905 |
Identified intangible liabilities, net |
5,805 |
|
6,095 |
Financing obligations |
41,101 |
|
41,756 |
Operating lease liabilities |
219,767 |
|
225,502 |
Security deposits, prepaid rent and other liabilities |
48,933 |
|
76,134 |
Total liabilities |
2,560,632 |
|
3,118,755 |
|
|
|
|
Commitments and contingencies |
|
|
|
|
|
|
|
Redeemable noncontrolling interests |
11,636 |
|
33,843 |
|
|
|
|
Equity: |
|
|
|
Stockholders' equity: |
|
|
|
Preferred stock, issued and outstanding |
— |
|
— |
Common Stock,
65,372,222 shares issued and outstanding as of
issued and outstanding as of |
644 |
|
— |
Class T common stock,
19,552,425 and 19,552,856 shares issued and outstanding as of
and |
194 |
|
194 |
Class I common stock,
46,673,320 shares issued and outstanding as of both
|
467 |
|
467 |
Additional paid-in capital |
3,275,252 |
|
2,548,307 |
Accumulated deficit |
(1,313,190) |
|
(1,276,222) |
Accumulated other comprehensive loss |
(2,468) |
|
(2,425) |
Total stockholders' equity |
1,960,899 |
|
1,270,321 |
Noncontrolling interests |
170,263 |
|
155,014 |
Total equity |
2,131,162 |
|
1,425,335 |
Total liabilities, redeemable noncontrolling interests and equity |
$ 4,703,430 |
|
$ 4,577,933 |
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS
For the Three Months Ended (In thousands, except share and per share amounts) (Unaudited) |
|||
|
|||
|
Three Months Ended |
||
|
2024 |
|
2023 |
Revenues: |
|
|
|
Resident fees and services |
$ 452,118 |
|
$ 408,630 |
Real estate revenue |
47,415 |
|
43,596 |
Total revenues |
499,533 |
|
452,226 |
Expenses: |
|
|
|
Property operating expenses |
403,629 |
|
370,146 |
Rental expenses |
13,727 |
|
15,195 |
General and administrative |
11,828 |
|
13,053 |
Business acquisition expenses |
2,782 |
|
332 |
Depreciation and amortization |
42,767 |
|
44,670 |
Total expenses |
474,733 |
|
443,396 |
Other income (expense): |
|
|
|
Interest expense: |
|
|
|
Interest expense (including amortization of deferred financing costs, debt discount/premium and loss on debt extinguishments) |
(36,438) |
|
(39,011) |
Gain (loss) in fair value of derivative financial instruments |
6,417 |
|
(195) |
Gain (loss) on dispositions of real estate investments, net |
2,263 |
|
(132) |
Loss from unconsolidated entities |
(1,205) |
|
(306) |
Gain on re-measurement of previously held equity interest |
— |
|
726 |
Foreign currency (loss) gain |
(426) |
|
1,008 |
Other income |
1,863 |
|
1,608 |
Total net other expense |
(27,526) |
|
(36,302) |
Loss before income taxes |
(2,726) |
|
(27,472) |
Income tax expense |
(278) |
|
(143) |
Net loss |
(3,004) |
|
(27,615) |
Net (income) loss attributable to noncontrolling interests |
(888) |
|
1,743 |
Net loss attributable to controlling interest |
$ (3,892) |
|
$ (25,872) |
Net loss per share of Common Stock, Class T common stock and Class I common stock attributable to controlling interest — basic and diluted |
$ (0.04) |
|
$ (0.39) |
Weighted average number of shares of Common Stock, Class T common stock and Class I common stock outstanding — basic and diluted |
104,295,142 |
|
66,026,173 |
|
|
|
|
Net loss |
$ (3,004) |
|
$ (27,615) |
Other comprehensive (loss) income: |
|
|
|
Foreign currency translation adjustments |
(43) |
|
122 |
Total other comprehensive (loss) income |
(43) |
|
122 |
Comprehensive loss |
(3,047) |
|
(27,493) |
Comprehensive (income) loss attributable to noncontrolling interests |
(888) |
|
1,743 |
Comprehensive loss attributable to controlling interest |
$ (3,935) |
|
$ (25,750) |
FFO and Normalized FFO Reconciliation
For the Three Months Ended (In thousands, except share and per share amounts) (Unaudited) |
|||
|
|||
|
Three Months Ended |
||
|
2024 |
|
2023 |
Net loss |
$ (3,004) |
|
$ (27,615) |
Depreciation and amortization related to real estate — consolidated properties |
42,729 |
|
44,632 |
Depreciation and amortization related to real estate — unconsolidated entities |
186 |
|
63 |
(Gain) loss on dispositions of real estate investments, net — consolidated properties |
(2,263) |
|
132 |
Net (income) loss attributable to noncontrolling interests |
(888) |
|
1,743 |
Gain on re-measurement of previously held equity interest |
— |
|
(726) |
Depreciation, amortization, impairments, net gain/loss on dispositions and gain on re-measurement — noncontrolling interests |
(5,462) |
|
(6,538) |
NAREIT FFO attributable to controlling interest |
$ 31,298 |
|
$ 11,691 |
|
|
|
|
Business acquisition expenses |
$ 2,782 |
|
$ 332 |
Amortization of above- and below-market leases |
426 |
|
8,675 |
Amortization of closing costs — debt security investments |
76 |
|
65 |
Change in deferred rent |
(589) |
|
(60) |
Non-cash impact of changes to equity instruments |
1,935 |
|
1,072 |
Capitalized interest |
(134) |
|
(26) |
Loss on debt extinguishments |
1,280 |
|
— |
(Gain) loss in fair value of derivative financial instruments |
(6,417) |
|
195 |
Foreign currency loss (gain) |
426 |
|
(1,008) |
Adjustments for unconsolidated entities |
(110) |
|
(74) |
Adjustments for noncontrolling interests |
125 |
|
(633) |
Normalized FFO attributable to controlling interest |
$ 31,098 |
|
$ 20,229 |
Weighted average common shares outstanding — basic and diluted |
104,295,142 |
|
66,026,173 |
Net loss per common share attributable to controlling interest — basic and diluted |
$ (0.04) |
|
$ (0.39) |
NAREIT FFO per common share attributable to controlling interest — basic and diluted |
$ 0.30 |
|
$ 0.18 |
Normalized FFO per common share attributable to controlling interest — basic and diluted |
$ 0.30 |
|
$ 0.31 |
Adjusted EBITDA Reconciliation
For the Three Months Ended (In thousands) (Unaudited) |
|
|
|
Net loss |
$ (3,004) |
|
|
Adjustments: |
|
Loss from unconsolidated entities |
1,205 |
Interest expense (including amortization of deferred financing costs, debt discount/premium and loss on debt extinguishments) |
36,438 |
Income tax expense |
278 |
Depreciation and amortization (including amortization of above/below market leases and right-of-use assets and accretion of lease liabilities) |
43,784 |
Straight line rent |
(1,132) |
Foreign currency loss |
426 |
Gain in fair value of derivative financial instruments |
(6,417) |
EBITDA |
$ 71,578 |
|
|
Non-cash stock-based compensation expense |
1,935 |
Business acquisition expenses |
2,782 |
Gain on dispositions of real estate investments, net |
(2,263) |
Non-recurring one-time items |
212 |
|
|
Adjusted EBITDA |
$ 74,244 |
Cash NOI Reconciliation
For the Three Months Ended (In thousands) (Unaudited) |
|||
|
|||
|
Three Months Ended |
||
|
2024 |
|
2023 |
Net loss |
$ (3,004) |
|
$ (27,615) |
General and administrative |
11,828 |
|
13,053 |
Business acquisition expenses |
2,782 |
|
332 |
Depreciation and amortization |
42,767 |
|
44,670 |
Interest expense |
36,438 |
|
39,011 |
(Gain) loss in fair value of derivative financial instruments |
(6,417) |
|
195 |
(Gain) loss on dispositions of real estate investments, net |
(2,263) |
|
132 |
Loss from unconsolidated entities |
1,205 |
|
306 |
Gain on re-measurement of previously held equity interests |
— |
|
(726) |
Foreign currency loss (gain) |
426 |
|
(1,008) |
Other income |
(1,863) |
|
(1,608) |
Income tax expense |
278 |
|
143 |
Total NOI |
$ 82,177 |
|
$ 66,885 |
|
|
|
|
Straight line rent |
(1,132) |
|
(1,090) |
Facility rental expense |
8,840 |
|
9,645 |
Other non-cash adjustments |
391 |
|
8,614 |
COVID subsidies |
— |
|
(143) |
Consolidated Cash NOI |
$ 90,276 |
|
$ 83,911 |
|
|
|
|
Cash NOI attributable to noncontrolling interest (1) |
(12,714) |
|
(10,789) |
Pro-Rata Cash NOI |
$ 77,562 |
|
$ 73,122 |
|
|
|
|
|
|
|
|
(1) |
All quarters are based upon ownership percentage as of the most recent quarter end. |
Same-Store NOI Reconciliation
For the Three Months Ended (In thousands) (Unaudited) |
|||
|
|||
|
Three Months Ended |
||
|
2024 |
|
2023 |
ISHC |
|
|
|
NOI |
$ 41,980 |
|
$ 33,409 |
Facility rental expense |
8,840 |
|
9,645 |
Cash NOI attributable to noncontrolling interest (1) |
(12,484) |
|
(10,577) |
Cash NOI |
$ 38,336 |
|
$ 32,477 |
New acquisitions/dispositions/transitions |
(4,844) |
|
(4,554) |
Same-Store NOI |
$ 33,492 |
|
$ 27,923 |
|
|
|
|
Outpatient Medical |
|
|
|
NOI |
$ 20,978 |
|
$ 23,075 |
Straight line rent |
(158) |
|
(393) |
Other non-cash adjustments |
164 |
|
187 |
Cash NOI |
$ 20,984 |
|
$ 22,869 |
New acquisitions/dispositions/transitions |
(75) |
|
(2,247) |
|
(834) |
|
(752) |
Same-Store NOI |
$ 20,075 |
|
$ 19,870 |
|
|
|
|
SHOP |
|
|
|
NOI |
$ 6,509 |
|
$ 5,075 |
Other non-cash adjustments |
— |
|
(40) |
COVID subsidies |
— |
|
(143) |
Cash NOI attributable to noncontrolling interest (1) |
(46) |
|
(30) |
Cash NOI |
$ 6,463 |
|
$ 4,862 |
New acquisitions/dispositions/transitions |
784 |
|
557 |
Development conversion |
540 |
|
412 |
Same-Store NOI |
$ 7,787 |
|
$ 5,831 |
|
|
|
|
|
|
|
|
NOI |
$ 12,710 |
|
$ 5,326 |
Straight line rent |
(974) |
|
(697) |
Other non-cash adjustments |
227 |
|
8,467 |
Cash NOI attributable to noncontrolling interest (1) |
(184) |
|
(182) |
Cash NOI |
$ 11,779 |
|
$ 12,914 |
Debt security investment |
(2,081) |
|
(1,970) |
New acquisitions/dispositions/transitions |
— |
|
(1,653) |
|
(373) |
|
(352) |
Same-Store NOI |
$ 9,325 |
|
$ 8,939 |
Same-Store NOI Reconciliation – (Continued)
For the Three Months Ended (In thousands) (Unaudited) |
|||
|
|||
|
Three Months Ended |
||
|
2024 |
|
2023 |
Total |
|
|
|
NOI |
$ 82,177 |
|
$ 66,885 |
Straight line rent |
(1,132) |
|
(1,090) |
Facility rental expense |
8,840 |
|
9,645 |
Other non-cash adjustments |
391 |
|
8,614 |
COVID subsidies |
— |
|
(143) |
Cash NOI attributable to noncontrolling interest (1) |
(12,714) |
|
(10,789) |
Cash NOI |
$ 77,562 |
|
$ 73,122 |
Debt security investment |
(2,081) |
|
(1,970) |
New acquisitions/dispositions/transitions |
(4,135) |
|
(7,897) |
Development conversion |
540 |
|
412 |
|
(1,207) |
|
(1,104) |
Same-Store NOI |
$ 70,679 |
|
$ 62,563 |
|
|
|
|
|
|
|
|
(1) |
All quarters are based upon ownership percentage as of the most recent quarter end. |
Same-Store Revenue Reconciliation
For the Three Months Ended and Years Ended (In thousands) (Unaudited) |
|||
|
|||
|
Three Months Ended |
||
|
2024 |
|
2023 |
ISHC |
|
|
|
GAAP revenue |
$ 393,122 |
|
$ 361,770 |
Cash revenue attributable to noncontrolling interest (1) |
(96,569) |
|
(88,867) |
Cash revenue |
$ 296,553 |
|
$ 272,903 |
Revenue attributable to non-Same-Store properties |
(93,786) |
|
(84,108) |
Same-Store revenue |
$ 202,767 |
|
$ 188,795 |
|
|
|
|
Outpatient Medical |
|
|
|
GAAP revenue |
$ 34,067 |
|
$ 37,483 |
Straight line rent |
(158) |
|
(393) |
Other non-cash adjustments |
(185) |
|
(119) |
Cash revenue |
$ 33,724 |
|
$ 36,971 |
Revenue attributable to non-Same-Store properties |
(155) |
|
(3,983) |
Revenue attributable to |
(1,266) |
|
(1,149) |
Same-Store revenue |
$ 32,303 |
|
$ 31,839 |
|
|
|
|
SHOP |
|
|
|
GAAP revenue |
$ 58,996 |
|
$ 46,860 |
Cash revenue attributable to noncontrolling interest (1) |
(276) |
|
(379) |
Cash revenue |
$ 58,720 |
|
$ 46,481 |
Revenue attributable to non-Same-Store properties |
(16,053) |
|
(7,613) |
Revenue attributable to development conversion |
(270) |
|
(591) |
Same-Store revenue |
$ 42,397 |
|
$ 38,277 |
Same-Store Revenue Reconciliation – (Continued)
For the Three Months Ended and Years Ended (In thousands) (Unaudited) |
|||||||
|
|||||||
|
Three Months Ended |
||||||
|
2024 |
|
2023 |
||||
|
|
|
|
||||
GAAP revenue |
$ 13,348 |
|
$ 6,113 |
||||
Straight line rent |
(974) |
|
(697) |
||||
Other non-cash adjustments |
210 |
|
8,468 |
||||
Cash revenue attributable to noncontrolling interest (1) |
(186) |
|
(182) |
||||
Cash revenue |
$ 12,398 |
|
$ 13,702 |
||||
Debt security investment |
(2,081) |
|
(1,970) |
||||
Revenue attributable to non-Same-Store properties |
— |
|
(1,805) |
||||
Revenue attributable to |
(458) |
|
(477) |
||||
Same-Store revenue |
$ 9,859 |
|
$ 9,450 |
||||
|
|
|
|
||||
Total |
|
|
|
||||
GAAP revenue |
$ 499,533 |
|
$ 452,226 |
||||
Straight line rent |
(1,132) |
|
(1,090) |
||||
Other non-cash adjustments |
25 |
|
8,349 |
||||
Cash revenue attributable to noncontrolling interest (1) |
(97,031) |
|
(89,428) |
||||
Cash revenue |
$ 401,395 |
|
$ 370,057 |
||||
Debt security investment |
(2,081) |
|
(1,970) |
||||
Revenue attributable to non-Same-Store properties |
(109,994) |
|
(97,509) |
||||
Revenue attributable to development conversion |
(270) |
|
(591) |
||||
Revenue attributable to |
(1,724) |
|
(1,626) |
||||
Same-Store revenue |
$ 287,326 |
|
$ 268,361 |
|
|
|
|
|
|
|
|
(1) |
All quarters are based upon ownership percentage as of the most recent quarter end. |
Earnings Outlook Reconciliation
For the Year Ending (In millions, except per share amounts) (Unaudited) |
|||
|
|||
|
Low |
|
High |
Net (loss) income attributable to common stockholders |
$ (4.15) |
|
$ 3.19 |
Depreciation and amortization(1) |
147.26 |
|
147.26 |
NAREIT FFO attributable to common stockholders |
143.11 |
|
150.45 |
|
|
|
|
Amortization of other intangible assets(1) |
$ 1.66 |
|
$ 1.66 |
Change in deferred rent(1) |
(0.42) |
|
(0.42) |
Non-cash impact of changes to equity plan(1) |
6.04 |
|
6.04 |
Other adjustments |
(0.80) |
|
(0.80) |
Normalized FFO attributable to common stockholders |
$ 149.58 |
|
$ 156.92 |
|
|
|
|
Net (loss) income per common share |
$ (0.03) |
|
$ 0.03 |
|
|
|
|
NAREIT FFO per common share |
$ 1.13 |
|
$ 1.19 |
|
|
|
|
Normalized FFO per common share |
$ 1.18 |
|
$ 1.24 |
|
|
|
|
Weighted average diluted shares |
126.6 |
|
126.6 |
|
|
|
|
Total Portfolio Same-Store NOI growth |
5.00 % |
|
7.00 % |
|
|
|
|
Segment-Level Same-Store NOI growth: |
|
|
|
ISHC |
8.00 % |
|
10.00 % |
Outpatient Medical |
(0.50) % |
|
0.00 % |
SHOP |
25.00 % |
|
30.00 % |
Triple-Net Leased |
1.00 % |
|
3.00 % |
|
|
|
|
|
|
|
|
(1) |
Amounts presented net of noncontrolling interests' share and AHR's share of unconsolidated entities. |
Definitions
Adjusted EBITDA: EBITDA excluding the impact of stock-based compensation expense, acquisition and pursuit costs, gain (loss) on sales of real estate, unrealized foreign currency gain (loss), change in fair value of financial instruments, impairment of real estate assets, lease termination revenue, non-recurring items, and adjusted for non-controlling interest.
Cash NOI: NOI excluding the impact of, without duplication, (1) non-cash items such as straight-line rent and the amortization of lease intangibles, (2) third-party facility rent payments and (3) other items set forth in the Cash NOI reconciliation included herein. Both Cash NOI and Same-Store NOI include ownership and other adjustments.
EBITDA: A non-GAAP financial measure that is defined as earnings before interest, taxes, depreciation and amortization.
GAAP revenue: Revenue recognized in accordance with Generally Accepted Accounting Principles ("GAAP"), which includes straight line rent and other non-cash adjustments.
ISHC: Integrated senior health campuses include a range of senior care, including independent living, assisted living, memory care, skilled nursing services and certain ancillary businesses. Integrated senior health campuses are predominantly operated utilizing a RIDEA structure.
NAREIT FFO or FFO: Funds from operations attributable to controlling interest; a non-GAAP financial measure, consistent with the standards established by the White Paper on FFO approved by the
Net Debt: Total long-term debt, excluding operating lease liabilities, less cash and cash equivalents and restricted cash pertaining to debt.
NOI: Net operating income; a non-GAAP financial measure that is defined as net income (loss), computed in accordance with GAAP, generated from properties before general and administrative expenses, business acquisition expenses, depreciation and amortization, interest expense, gain or loss on dispositions, impairment of real estate investments, impairment of goodwill, income or loss from unconsolidated entities, gain on re-measurement of previously held equity interest, foreign currency gain or loss, other income and income tax benefit or expense.
Normalized FFO attributable to controlling interest or NFFO: FFO further adjusted for the following items included in the determination of GAAP net income (loss): expensed acquisition fees and costs, which we refer to as business acquisition expenses; amounts relating to changes in deferred rent and amortization of above and below-market leases (which are adjusted in order to reflect such payments from a GAAP accrual basis); the non-cash impact of changes to our equity instruments; non-cash or non-recurring income or expense; the noncash effect of income tax benefits or expenses; capitalized interest; impairment of goodwill; amortization of closing costs on debt investments; mark-to-market adjustments included in net income (loss); gains or losses included in net income (loss) from the extinguishment or sale of debt, hedges, foreign exchange, derivatives or securities holdings where trading of such holdings is not a fundamental attribute of the business plan; after adjustments for consolidated and unconsolidated partnerships and joint ventures, with such adjustments calculated to reflect Normalized FFO on the same basis.
Occupancy: With respect to OM, the percentage of total rentable square feet leased and occupied, including month-to-month leases, as of the date reported. With respect to all other property types, occupancy represents average quarterly operating occupancy based on the most recent quarter of available data. The Company uses unaudited, periodic financial information provided solely by tenants to calculate occupancy and has not independently verified the information. Occupancy metrics are reflected at our Pro-Rata share.
Outpatient Medical or OM: Outpatient Medical buildings.
Pro-Rata: As of
RIDEA: Used to describe properties within the portfolio that utilize the RIDEA structure as described in "RIDEA structure".
RIDEA structure: A structure permitted by the REIT Investment Diversification and Empowerment Act of 2007, pursuant to which we lease certain healthcare real estate properties to a wholly-owned taxable REIT subsidiary ("TRS"), which in turn contracts with an eligible independent contractor ("EIK") to operate such properties for a fee. Under this structure, the EIK receives management fees, and the TRS receives revenue from the operation of the healthcare real estate properties and retains, as profit, any revenue remaining after payment of expenses (including intercompany rent paid to us and any taxes at the TRS level) necessary to operate the property. Through the RIDEA structure, in addition to receiving rental revenue from the TRS, we retain any after-tax profit from the operation of the healthcare real estate properties and benefit from any improved operational performance while bearing the risk of any decline in operating performance at the properties.
Same-Store or SS: Properties owned and consolidated the full period in both comparison periods and that are not otherwise excluded. Properties are excluded from Same-Store if they are: (1) sold, classified as held for sale or properties whose operations were classified as discontinued operations in accordance with GAAP; (2) impacted by materially disruptive events, such as flood or fire for an extensive period of time; or (3) scheduled to undergo or currently undergoing major expansions/renovations or business model transitions or have transitioned business models after the start of the prior comparison period.
Same-Store NOI or SS NOI: Cash NOI for our Same-Store properties. Same-Store NOI is used to evaluate the operating performance of our properties using a consistent population which controls for changes in the composition of our portfolio. Both Cash NOI and Same-Store NOI include ownership and other adjustments.
SHOP: Senior housing operating properties.
Square Feet or Sq. Ft.: Net rentable square feet calculated utilizing
Total Debt: The principal balances of the Company's revolving credit facility, term loans and secured indebtedness as reported in the Company's consolidated financial statements.
Trilogy: Trilogy Investors, LLC; one of our consolidated joint ventures, in which we indirectly owned a 75.4% interest as of
Triple-net leased: A lease where the tenant is responsible for making rent payments, maintaining the leased property and paying property taxes and other expenses.
Contact:
Email: investorrelations@ahcreit.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/american-healthcare-reit-ahr-announces-first-quarter-2024-results-302143810.html
SOURCE